The gold standard of medical research, the randomized controlled trial, has been taking a bit of a beating lately. An entire issue of the journal Social Science and Medicine was recently devoted to it, with many articles pointing to shortcomings. Others have argued that randomized controlled trials often can’t address the questions that patients and...

Telehealth is here to stay, but it will go through an evolution like all new technology shifts. A new study evaluated performance of teledermatology. The results were mixed. There were incorrect diagnoses and missed diagnoses. Treatment recommendations were not always consistent with guidelines. Prescriptions frequently lacked disclosure about possible adverse effects....